2,389 results on '"Kieser, A."'
Search Results
2. Long noncoding <scp>RNAs</scp> are substrates for cytoplasmic capping enzyme
- Author
-
Avik Mukherjee, Safirul Islam, Rachel E. Kieser, Daniel L. Kiss, and Chandrama Mukherjee
- Subjects
Structural Biology ,Genetics ,Biophysics ,Cell Biology ,Molecular Biology ,Biochemistry - Published
- 2023
3. The Dawning of a New Enterprise: RNA Therapeutics for the Skin
- Author
-
Rachel E. Kieser, Shaheerah Khan, Nada Bejar, and Daniel L. Kiss
- Subjects
Geography, Planning and Development ,General Earth and Planetary Sciences ,Water Science and Technology - Abstract
Despite being under development for decades, RNA therapeutics have only recently emerged as viable drug platforms. The COVID-19 mRNA vaccines have demonstrated the promise and power of the platform technology. In response, novel RNA drugs are entering clinical trials at an accelerating rate. As the skin is the largest and most accessible organ, it has always been a preferred target for drug discovery. This holds true for RNA therapies as well, and multiple candidate RNA-based drugs are currently in development for an array of skin conditions. In this mini review, we catalog the RNA therapies currently in clinical trials for different dermatological diseases. We summarize the main types of RNA-related drugs and use examples of drugs currently in development to illustrate their key mechanism of action.
- Published
- 2023
4. Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification
- Author
-
Emily F. Thompson, Jutta Huvila, Amy Jamieson, Samuel Leung, Amy Lum, Saul Offman, Alice Lytwyn, Mona Lisa Sur, Lynn Hoang, Julie Irving, Nicholas van der Westhuizen, Chantale Morin, Cyrille Bicamumpaka, Nazilla Azordegan, François Gougeon, Kaoutar Ennour-Idrissi, Janine Senz, Melissa K. McConechy, Rosalia Aguirre-Hernandez, Victoria Lui, Carolyn Kuo, Cassidy Bell, Taylor Salisbury, James Lawson, Ellen He, Shanzhao Wang, Derek Chiu, Sarah Kean, Vanessa Samouëlian, Shannon Salvador, Walter Gotlieb, Limor Helpman, Stephanie Scott, Christoph Wohlmuth, Danielle Vicus, Marie Plante, Aline Talhouk, David Huntsman, Carlos Parra-Herran, Mary Kinloch, Katherine Grondin, C. Blake Gilks, Jessica N. McAlpine, Jessica McAlpine, Anita Agrawal, Omar Al-Nourhji, Alon Altman, Marcus Bernardini, C. Bicamumpaka, Mark Carey, Blaise Clarke, Nazila Azordegan, Bojana Djordjevic, Laurie Elit, Alex Ferenczy, Sarah Finlayson, Anthony Fyles, Hugo Garneau, France Gauthier, Prafull Ghatage, Blake Gilks, Kathy Han, Hal Hirte, Fleur Huang, Katharina Kieser, Mary Kinlloch, Iwa Kong, Aalok Kumar, Janice Kwon, Sandra Lee, Eric Leung, Helen Mackay, Eve-Lyne Marchand, Justin Mcginnis, Dianne Miller, Gregg Nelson, Manuela Pelmus, Annick Pina, Anna Plotkin, Diane Provencher, Anna Tinker, Alicia Tone, Stephen Welch, Nicholas Westhuizen, and Katarzyna Jerzak
- Subjects
Pathology and Forensic Medicine - Published
- 2022
5. A Comprehensive Comparison of Additional Benefit Assessment Methods Applied by Institute for Quality and Efficiency in Health Care and European Society for Medical Oncology for Time-to-Event Endpoints After Significant Phase III Trials—A Simulation Study
- Author
-
Christopher A, Büsch, Johannes, Krisam, and Meinhard, Kieser
- Subjects
Health Policy ,Public Health, Environmental and Occupational Health - Abstract
After a successful Marketing Authorization Application for clinical trials with time-to-event endpoints, the degree of the added benefit from new treatments remains unknown and needs to be assessed. Unfortunately, until now no clear definition for added benefit determination of a treatment exists. Nevertheless, European authorities / societies have developed 2 "additional benefit assessment" methods, which have up to now not been compared: the European Society for Medical Oncology (ESMO) developed a dual rule considering relative and absolute benefit. The German Institute for Quality and Efficiency in Health Care (IQWiG) developed a method using upper 95% hazard ratio confidence interval.We evaluate and compare both methods in an extensive simulation study including different censoring rates, failure time distributions, and treatment effects for sample size calculation. The methods' performance is assessed via Receiver Operating Characteristic curves, Spearman correlation, and percentage of achieved maximal scores.The results show that IQWiG's method has in many situations a lower maximal scoring proportion than ESMO's rule, that is, up to 28.5% versus 94.7%. Various failure time distributions lead to strongly changed maximal scoring percentages for ESMO. High positive correlation between the methods is present for moderate treatment effects.IQWiG's method is usually more conservative than ESMO's. ESMO's rule tends to be more susceptible for various failure time distributions. Using the lower confidence interval limit seems to be a better solution resulting in a higher true-positive rate without increasing the false-positive rate. Thus, IQWiG's method might need to be adapted accordingly to achieve a better overall classification.
- Published
- 2022
6. Characterization of the isobar separator for anions integrated into the A. E. Lalonde laboratory’s 3 MV AMS system
- Author
-
Erin L. Flannigan, Jean-François Alary, William E. Kieser, Lisa M. Cousins, and Gholamreza Javahery
- Subjects
Nuclear and High Energy Physics ,Instrumentation - Published
- 2022
7. Multisystem Inflammatory Syndrome in Children (MIS-C): ähnlich und doch ganz anders als das Kawasaki-Syndrom
- Author
-
Patricia Kieser and Miriam Schell
- Abstract
ZUSAMMENFASSUNGIm Zeitraum vom 10. November 2020 bis zum 26. Dezember 2021 wurden im Katholischen Kinderkrankenhaus Wilhelmstift in Hamburg sechs Kinder mit MIS-C behandelt. Mögliche Differenzialdiagnosen wie das Kawasaki-Syndrom (KS), Toxisches Schocksyndrom sowie die Hämophagozytische Lymphohistiozytose konnten unter anderem durch den Nachweis einer positiven SARS-CoV-2-Serologie ausgeschlossen werden. Anders als beim KS sind Kinder mit MIS-C älter und fallen durch eine führende kardiale und abdominelle Symptomatik auf. Eine mit ventrikulärer Dysfunktion einhergehende Kreislaufinstabilität macht in der Regel eine intensivmedizinische Behandlung notwendig. Trotz des schweren Krankheitsverlaufs ist die MIS-C-Erkrankung unter adäquater Therapie (intravenöse Immunglobuline, Methylprednisolon, Azetylsalizylsäure sowie hämodynamischer Support) mit einer guten Prognose verbunden.
- Published
- 2022
8. Temporal Changes in the Use of Wild Medicinal Plants in Trentino–South Tyrol, Northern Italy
- Author
-
Pieroni, Giulia Mattalia, Felina Graetz, Matthes Harms, Anna Segor, Alessio Tomarelli, Victoria Kieser, Stefan Zerbe, and Andrea
- Subjects
Alps ,biocultural diversity ,borders ,ethnomedicine ,historical ethnobotany ,local ecological knowledge ,mountain regions - Abstract
Mountain regions are fragile ecosystems and often host remarkably rich biodiversity, and thus they are especially under threat from ongoing global changes. Located in the Eastern Alps, Trentino–South Tyrol is bioculturally diverse but an understudied region from an ethnobotanical perspective. We explored the ethnomedicinal knowledge of the area from a cross-cultural and diachronic perspective by conducting semi-structured interviews with 22 local inhabitants from Val di Sole (Trentino) and 30 from Überetsch–Unterland (South Tyrol). Additionally, we compared the results with ethnobotanical studies conducted in Trentino and South Tyrol over 25 years ago. The historical comparison revealed that about 75% of the plants currently in use were also used in the past in each study region. We argue that the adoption of “new” medicinal species could have occurred through printed and social media and other bibliographical sources but may also be due to limitations in conducting the comparison (i.e., different taxonomic levels and different methodologies). The inhabitants of Val di Sole and Überetsch–Unterland have shared most medicinal plants over the past few decades, yet the most used species diverge (perhaps due to differences in local landscapes), and in South Tyrol, people appear to use a higher number of medicinal plants, possibly because of the borderland nature of the area.
- Published
- 2023
- Full Text
- View/download PDF
9. Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics
- Author
-
Lina Lu, Jennifer Rui Wang, Ying C. Henderson, Shanshan Bai, Jie Yang, Min Hu, Cheng-Kai Shiau, Timothy Pan, Yuanqing Yan, Tuan M. Tran, Jianzhuo Li, Rachel Kieser, Xiao Zhao, Jiping Wang, Roza Nurieva, Michelle D. Williams, Maria E. Cabanillas, Ramona Dadu, Naifa Lamki Busaidy, Mark Zafereo, Nicholas Navin, Stephen Y. Lai, and Ruli Gao
- Subjects
General Medicine - Published
- 2023
10. Deficiency of germinal center kinase TRAF2 and NCK-interacting kinase (TNIK) in B cells does not affect atherosclerosis
- Author
-
Bram W. van Os, Pascal J. H. Kusters, Myrthe den Toom, Linda Beckers, Claudia M. van Tiel, Winnie G. Vos, Elize de Jong, Arnd Kieser, Cindy van Roomen, Christoph J. Binder, Myrthe E. Reiche, Menno P. de Winther, Laura A. Bosmans, and Esther Lutgens
- Subjects
Cardiology and Cardiovascular Medicine - Abstract
BackgroundAtherosclerosis is the underlying cause of many cardiovascular diseases, such as myocardial infarction or stroke. B cells, and their production of pro- and anti-atherogenic antibodies, play an important role in atherosclerosis. In B cells, TRAF2 and NCK-interacting Kinase (TNIK), a germinal center kinase, was shown to bind to TNF-receptor associated factor 6 (TRAF6), and to be involved in JNK and NF-κB signaling in human B cells, a pathway associated with antibody production.ObjectiveWe here investigate the role of TNIK-deficient B cells in atherosclerosis.ResultsApoE−/−TNIKfl/fl (TNIKBWT) and ApoE−/−TNIKfl/flCD19-cre (TNIKBKO) mice received a high cholesterol diet for 10 weeks. Atherosclerotic plaque area did not differ between TNIKBKO and TNIKBWT mice, nor was there any difference in plaque necrotic core, macrophage, T cell, α-SMA and collagen content. B1 and B2 cell numbers did not change in TNIKBKO mice, and marginal zone, follicular or germinal center B cells were unaffected. Total IgM and IgG levels, as well as oxidation specific epitope (OSE) IgM and IgG levels, did not change in absence of B cell TNIK. In contrast, plasma IgA levels were decreased in TNIKBKO mice, whereas the number of IgA+ B cells in intestinal Peyer's patches increased. No effects could be detected on T cell or myeloid cell numbers or subsets.ConclusionWe here conclude that in hyperlipidemic ApoE−/− mice, B cell specific TNIK deficiency does not affect atherosclerosis.
- Published
- 2023
- Full Text
- View/download PDF
11. Is There a Nerve-free Zone in Which a Subscapularis Split Can Safely be Performed? An Anatomical Study Using Embalmed Specimens
- Author
-
Siwetz, Martin, Kieser, David Christopher, Ondruschka, Benjamin, Pretterklieber, Bettina, Hammer, Niels, and Publica
- Subjects
Orthopedics and Sports Medicine ,Surgery ,General Medicine - Abstract
Background: The subscapularis muscle, which is part of the rotator cuff, is located anterior to the shoulder. In anterior approaches to the shoulder, its supplying nerves are at risk of iatrogenic injury, which may cause postoperative complications. It is unclear whether there is any nerve-free zone in which a subscapularis split can be performed without risking nerve damage. Questions/purposes: In an anatomical study, we asked: (1) With the arm abducted 60° and externally rotated, what are the median and shortest distances between the entrance point of the subscapular nerves into subscapularis muscle and the myotendinous junction of this muscle? (2) What are those distances in other positions of the shoulder? (3) Did those measurements differ between specimen sexes or sides? Methods: In 84 shoulders of 66 embalmed anatomic specimens, the distance from the myotendinous junction of the subscapularis muscle to the entrance points of the subscapular nerves into the subscapularis muscle was measured using an inelastic thread and a millimeter gauge with the arm abducted 60° and rotated externally. In 16 of 84 shoulders, which were selected randomly, after taking the measurements with the arm abducted 60° and rotated externally, arm positions were changed and further measurements were taken with the arm abducted 60° and rotated neutrally, abducted 60° and rotated internally, and abducted 90° and rotated externally. The positions of the entrance points were described with statistical parameters and compared between different sides, sexes, and joint positions. Measurements were verified using eight fresh-frozen shoulders, showing no difference in distances compared with embalmed specimens and confirming reproducibility of measurements. Absolute distances were used to minimize possible distortion when using correlations and for straightforwardness and clinical applicability. Results: The median (range) distance was 43 mm (24 to 64) for the upper subscapular nerve and 38 mm (23 to 59) for the lower subscapular nerve with the arm rotated externally and abducted 60°. In the 16 subsamples, internal rotation decreased the distance to 34 mm (24 to 49) and 31 mm (15 to 43), respectively, and maximal external rotation and 90° of abduction increased it up to 49 mm (30 to 64) and 41 mm (27 to 56). Comparison of left and right sides yielded no difference. Comparison of sexes showed distances for the lower subscapular nerve of 36 mm (23 to 54) in females versus 39 mm (24 to 60) in males. Conclusion: In no specimen did the nerve come closer than 23 mm medial to the myotendinous junction with the arm rotated externally and abducted. Therefore, not exceeding a distance of 20 mm medial to the myotendinous junction with the arm rotated externally seems to provide sufficient protection from nerve injury during surgery. Clinical Relevance: Based on the described zone of 20 mm medial to the myotendinous junction, the risk of nerve injury in a subscapularis split approach can be minimized.
- Published
- 2022
12. blindrecalc - An R Package for Blinded Sample Size Recalculation
- Author
-
Lukas Baumann, Maximilian Pilz, and Meinhard Kieser
- Subjects
Statistics and Probability ,Numerical Analysis ,Statistics, Probability and Uncertainty - Published
- 2022
13. Histories of Denial
- Author
-
Hans-Lukas Kieser
- Subjects
Archeology ,History ,Museology - Published
- 2022
14. FOREST PLANTATION DETECTION THROUGH DEEP SEMANTIC SEGMENTATION
- Author
-
F. B. J. R. Dallaqua, R. A. S. Rosa, B. Schultz, L. R. Faria, T. G. Rodrigues, C. G. Oliveira, M. E. J. Kieser, V. Malhotra, T. Dwyer, and D. S. Wolfe
- Abstract
Forest plantations play an important role ecologically, contribute to carbon sequestration and support billions of dollars of economic activity each year through sustainable forest management and forest sector value chains. As the global demand for forest products and services increases, the marketplace is seeking more reliable data on forest plantations. Remote sensing technologies allied with machine learning, and most recently deep learning techniques, provide valuable data for inventorying forest plantations and related valuation products. In this work, deep semantic segmentation with U-net architecture was used to detect forest plantation areas using Sentinel-2 and CBERS-4A images of different areas of Brazil. First, the U-net models were built from an area of the Centre-East of Paraná State, and then the best models were tested in 3 new areas that present different characteristics. The U-net models built with Sentinel-2 images achieved promising results for areas similar to the ones used in the training set, with F1-score ranging from 0.9171 to 0.9499 and with Kappa values between 0.8712 to 0.9272, demonstrating the feasibility of deep semantic segmentation to detect forest plantations.
- Published
- 2022
15. Optimal unplanned design modification in adaptive two‐stage trials
- Author
-
Maximilian Pilz, Carolin Herrmann, Geraldine Rauch, and Meinhard Kieser
- Subjects
Pharmacology ,Statistics and Probability ,Research Design ,Sample Size ,Humans ,Pharmacology (medical) - Abstract
Adaptive planning of clinical trials allows modifying the entire trial design at any time point mid-course. In this paper, we consider the case when a trial-external update of the planning assumptions during the ongoing trial makes an unforeseen design adaptation necessary. We take up the idea to construct adaptive designs with defined features by solving an optimization problem and apply it to the situation of unplanned design reassessment. By using the conditional error principle, we present an approach on how to optimally modify the trial design at an unplanned interim analysis while at the same time strictly protecting the type I error rate. This linking of optimal design planning and the conditional error principle allows sound reactions to unforeseen events that make a design reassessment necessary.
- Published
- 2022
16. Full Reperfusion Without Functional Independence After Mechanical Thrombectomy in the Anterior Circulation
- Author
-
Charlotte S. Weyland, Johannes A. Vey, Yahia Mokli, Manuel Feisst, Meinhard Kieser, Christian Herweh, Silvia Schönenberge, Markus A. Möhlenbruch, Martin Bendszus, Peter A. Ringleb, and Simon Nagel
- Subjects
Radiology, Nuclear Medicine and imaging ,Neurology (clinical) - Abstract
Background and Purpose Prediction of futile recanalization (FR), i.e. failure of long-term functional independence despite full reperfusion in mechanical thrombectomy (MT), is instrumental in patients undergoing endovascular therapy. Methods Retrospective single-center analysis of patients treated for anterior circulation LVO ensuing successful MT (mTICI 2c–3) between January 2014 and April 2019. FR was defined as modified Rankin Scale (mRS) 90 days after stroke onset > 2 or mRS > pre-stroke mRS. Multivariable analysis was performed with variables available before treatment initiation regarding their association with FR. Performance of the regression model was then compared with a model including parameters available after MT. Results Successful MT was experienced by 549/1146 patients in total. FR occurred in 262/549 (47.7%) patients. Independent predictors of FR were male sex, odds ratio (OR) with 95% confidence interval (CI) 1.98 (1.31–3.05, p 0.001), age (OR 1.05, CI 1.03–1.07, p p p 0.025), neutrophile-lymphocyte ratio (OR 1.03, CI 1.00–1.06, p 0.022), baseline ASPECTS (OR 0.77, CI 0.68–0.88, p p 0.016). The prediction model’s Area Under the Curve was 0.78 (CI 0.74–0.82) and increased with parameters available after MT to 0.86 (CI 0.83–0.89) with failure of early neurological improvement being the most important predictor of FR (OR 15.0, CI 7.2–33.8). Conclusion A variety of preinterventional factors may predict FR with substantial certainty, but the prediction model can still be improved by considering parameters only available after MT, in particular early neurological improvement.
- Published
- 2022
17. Obeid-Coronal Malalignment Classification Is Age Related and Independently Associated to Personal Reported Outcome Measurement Scores in the Nonfused Spine
- Author
-
Kieser, David Christopher, Boissiere, Louis, Bourghli, Anouar, Hayashi, Kazunori, Cawley, Derek, Yilgor, Caglar, Alanay, Ahmet, Acaroglu, Emre, Kleinstueck, Frank, Pizones, Javier, Pellise, Ferran, Perez-Grueso, Francisco Javier Sanchez, Obeid, Ibrahim, Grp, European Spine Study, Institut Català de la Salut, [Kieser DC] Department of Orthopaedic Surgery and Musculoskeletal Medicine, University of Otago, Christchurch School of Medicine, Christchurch, New Zealand. [Boissiere L, Hayashi K, Cawley D] L’Institut de la Colonne Vertébrale, CHU Pellegrin, Bordeaux, France. [Bourghli A] Orthopedic and Spinal Surgery Department, Kingdom Hospital, Riyadh, Saudi Arabia. [Yilgor C] Acibadem University School of Medicine, Istanbul, Turkey. [Pellise F] Unitat de Cirurgia de Columna, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, and Acibadem University Dspace
- Subjects
Pelvic tilt ,medicine.medical_specialty ,Multivariate analysis ,deformity ,Scoliosis ,spine ,Edat òssia ,medicine ,Deformity ,Columna vertebral - Malformacions - Cirurgia ,RC346-429 ,Epidemiology and Biostatistics::Epidemiology::Epidemiologic Studies::Epidemiology, Descriptive::Population Characteristics::Age Effect [PUBLIC HEALTH] ,Musculoskeletal Diseases::Bone Diseases::Bone Malalignment [DISEASES] ,scoliosis ,enfermedades musculoesqueléticas::enfermedades óseas::desviación ósea [ENFERMEDADES] ,Cobb angle ,business.industry ,epidemiología y bioestadística::epidemiología::estudios epidemiológicos::epidemiología descriptiva::Características de la Población::efecto edad [SALUD PÚBLICA] ,Confounding ,Otros calificadores::Otros calificadores::/cirugía [Otros calificadores] ,medicine.disease ,Sagittal plane ,Other subheadings::Other subheadings::/surgery [Other subheadings] ,Surgery ,medicine.anatomical_structure ,Coronal plane ,Neurology (clinical) ,Neurology. Diseases of the nervous system ,medicine.symptom ,business ,coronal malalignment - Abstract
Deformitat; Escoliosi; Columna vertebral Deformidad; Escoliosis; Espina dorsal Deformity; Scoliosis; Spine Objective To evaluate Obeid-coronal malalignment (O-CM) modifiers according to age, sagittal alignment, and patient-reported outcome measures (PROMs), in the mobile spine. Methods Retrospective review of a prospective multicenter adult spinal deformity (ASD) database with 1,243 (402 nonoperative, 841 operative) patients with no prior fusion surgery. Patients were included if they were aged over 18 years and were affected by spinal deformity defined by one of: Cobb angle ≥ 20°, pelvic tilt ≥ 25°, sagittal vertical axis ≥ 5 cm, thoracic kyphosis ≥ 60°. Patients were classified according to the O-CM classification and compared to coronally aligned patients. Multivariate analysis was performed on the relationship between PROMs and age, global tilt (GT) and coronal malalignment (CM). Results Four hundred forty-three patients had CM of more than 2 cm compared to 800 who did not. The distribution of these modifiers was correlated to age. After multivariate analysis, using age and GT as confounding factors, we found that before the age of 50 years, 2A1 patients had worse sex life and greater satisfaction than patients without CM. After 50 years of age, patients with CM (1A1, 1A2) had worse self-image and those with 2A2, 2B had worse self-image, satisfaction, and 36-item Short Form Health Survey physical function. Self-image was the consistent determinant of patients opting for surgery for all ages. Conclusion CM distribution according to O-CM modifiers is age dependent. A clear correlation between the coronal malalignment and PROMs exists when using the O-CM classification and in the mobile spine, this typically affects self-image and satisfaction. Thus, CM classified according to O-CM modifiers is correlated to PROMs and should be considered in ASD
- Published
- 2021
18. Framing Pasts and Futures at the Lausanne Conference
- Author
-
Hans-Lukas Kieser
- Published
- 2023
19. When Democracy Died
- Author
-
Hans-Lukas Kieser
- Abstract
The Treaty of Lausanne, signed in Switzerland in July 1923, officially settled the conflict between the Ottoman Empire and the Allied forces. Not only did the Treaty establish the borders of the modern Turkish republic, but it also defined boundaries, political systems, and understandings of citizenship in the newly formed post-Ottoman nation-states. Here, Hans-Lukas Kieser recounts how the eight dramatic months of the Lausanne Conference concluded more than ten years of war and genocide in the late Ottoman Empire. Crucially, the Treaty was in favour of a homogeneous Turkish state in Asia Minor and became the basis for the compulsory 'unmixing of people' that facilitated the persecution of minority groups, including Armenians, Kurds, and Arabs. Not only did this significant yet oft-overlooked treaty mark the end of the League of Nations' project of self-determination and security for small peoples, but it was crucial in shaping the modern Middle East, and dictatorships in Turkey and Europe.
- Published
- 2023
20. Supplementary Figure 1 from Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- Author
-
Guy Ungerechts, Christoph Springfeld, Volker Daniel, Matthias M. Gaida, Oliver Sedlaczek, Niels Halama, Dirk Jäger, Jutta Schreiber, Nicolas Hohmann, Athanasios Mavratzas, Christine E. Engeland, Bernard Huber, Michael Dahm, Ottheinz Krebs, Meinhard Kieser, Maximilian Pilz, Mieke Mertens, Jean Rommelaere, Veronika Frehtman, Assia L. Angelova, Barbara Leuchs, and Jacek Hajda
- Abstract
Overall Survival & Progression Free Survival
- Published
- 2023
21. Supplementary Table 4 from Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- Author
-
Guy Ungerechts, Christoph Springfeld, Volker Daniel, Matthias M. Gaida, Oliver Sedlaczek, Niels Halama, Dirk Jäger, Jutta Schreiber, Nicolas Hohmann, Athanasios Mavratzas, Christine E. Engeland, Bernard Huber, Michael Dahm, Ottheinz Krebs, Meinhard Kieser, Maximilian Pilz, Mieke Mertens, Jean Rommelaere, Veronika Frehtman, Assia L. Angelova, Barbara Leuchs, and Jacek Hajda
- Abstract
Supplementary Table 4
- Published
- 2023
22. Supplementary Table 2 from Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- Author
-
Guy Ungerechts, Christoph Springfeld, Volker Daniel, Matthias M. Gaida, Oliver Sedlaczek, Niels Halama, Dirk Jäger, Jutta Schreiber, Nicolas Hohmann, Athanasios Mavratzas, Christine E. Engeland, Bernard Huber, Michael Dahm, Ottheinz Krebs, Meinhard Kieser, Maximilian Pilz, Mieke Mertens, Jean Rommelaere, Veronika Frehtman, Assia L. Angelova, Barbara Leuchs, and Jacek Hajda
- Abstract
Supplementary Table 2
- Published
- 2023
23. Supplementary Figure 2 from Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- Author
-
Guy Ungerechts, Christoph Springfeld, Volker Daniel, Matthias M. Gaida, Oliver Sedlaczek, Niels Halama, Dirk Jäger, Jutta Schreiber, Nicolas Hohmann, Athanasios Mavratzas, Christine E. Engeland, Bernard Huber, Michael Dahm, Ottheinz Krebs, Meinhard Kieser, Maximilian Pilz, Mieke Mertens, Jean Rommelaere, Veronika Frehtman, Assia L. Angelova, Barbara Leuchs, and Jacek Hajda
- Abstract
Serum CA19-9 levels
- Published
- 2023
24. Supplementary Table 1 from Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- Author
-
Guy Ungerechts, Christoph Springfeld, Volker Daniel, Matthias M. Gaida, Oliver Sedlaczek, Niels Halama, Dirk Jäger, Jutta Schreiber, Nicolas Hohmann, Athanasios Mavratzas, Christine E. Engeland, Bernard Huber, Michael Dahm, Ottheinz Krebs, Meinhard Kieser, Maximilian Pilz, Mieke Mertens, Jean Rommelaere, Veronika Frehtman, Assia L. Angelova, Barbara Leuchs, and Jacek Hajda
- Abstract
Supplementary Table 1
- Published
- 2023
25. Data from Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- Author
-
Guy Ungerechts, Christoph Springfeld, Volker Daniel, Matthias M. Gaida, Oliver Sedlaczek, Niels Halama, Dirk Jäger, Jutta Schreiber, Nicolas Hohmann, Athanasios Mavratzas, Christine E. Engeland, Bernard Huber, Michael Dahm, Ottheinz Krebs, Meinhard Kieser, Maximilian Pilz, Mieke Mertens, Jean Rommelaere, Veronika Frehtman, Assia L. Angelova, Barbara Leuchs, and Jacek Hajda
- Abstract
Purpose:To investigate the safety, clinical efficacy, virus pharmacokinetics, shedding, and immune response after administration of an oncolytic parvovirus (H-1PV, ParvOryx) to patients with metastatic pancreatic ductal adenocarcinoma (PDAC) refractory to first-line therapy.Patients and Methods:This is a noncontrolled, single-arm, open-label, dose-escalating, single-center clinical trial. Seven patients with PDAC and at least one liver metastasis were included. ParvOryx was administered intravenously on 4 consecutive days and as an intralesional injection, 6 to 13 days thereafter. Altogether, three escalating dose levels were investigated. In addition, gemcitabine treatment was initiated on day 28.Results:ParvOryx showed excellent tolerability with no dose-limiting toxicities. One patient had a confirmed partial response and one patient revealed an unconfirmed partial response according to RECIST criteria. Both patients showed remarkably long surivial of 326 and 555 days, respectively. Investigation of pharmacokinetics and virus shedding revealed dose dependency with no excretion of active virus particles in saliva or urine and very limited excretion in feces. H-1PV nucleic acids were detected in tumor samples of four patients. All patients showed T-cell responses to viral proteins. An interesting immunologic pattern developed in tumor tissues and in blood of both patients with partial response suggesting immune activation after administration of ParvOryx.Conclusions:The trial met all primary objectives, revealed no environmental risks, and indicated favorable immune modulation after administration of ParvOryx. It can be considered a good basis for further systematic clinical development alone or in combination with immunomodulatory compounds.
- Published
- 2023
26. Supplementary Table 3 from Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- Author
-
Guy Ungerechts, Christoph Springfeld, Volker Daniel, Matthias M. Gaida, Oliver Sedlaczek, Niels Halama, Dirk Jäger, Jutta Schreiber, Nicolas Hohmann, Athanasios Mavratzas, Christine E. Engeland, Bernard Huber, Michael Dahm, Ottheinz Krebs, Meinhard Kieser, Maximilian Pilz, Mieke Mertens, Jean Rommelaere, Veronika Frehtman, Assia L. Angelova, Barbara Leuchs, and Jacek Hajda
- Abstract
Supplementary Table 3
- Published
- 2023
27. Supplementary Figure 4 from Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- Author
-
Guy Ungerechts, Christoph Springfeld, Volker Daniel, Matthias M. Gaida, Oliver Sedlaczek, Niels Halama, Dirk Jäger, Jutta Schreiber, Nicolas Hohmann, Athanasios Mavratzas, Christine E. Engeland, Bernard Huber, Michael Dahm, Ottheinz Krebs, Meinhard Kieser, Maximilian Pilz, Mieke Mertens, Jean Rommelaere, Veronika Frehtman, Assia L. Angelova, Barbara Leuchs, and Jacek Hajda
- Abstract
Virus shedding in urine and saliva
- Published
- 2023
28. Supplementary Figure 3 from Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- Author
-
Guy Ungerechts, Christoph Springfeld, Volker Daniel, Matthias M. Gaida, Oliver Sedlaczek, Niels Halama, Dirk Jäger, Jutta Schreiber, Nicolas Hohmann, Athanasios Mavratzas, Christine E. Engeland, Bernard Huber, Michael Dahm, Ottheinz Krebs, Meinhard Kieser, Maximilian Pilz, Mieke Mertens, Jean Rommelaere, Veronika Frehtman, Assia L. Angelova, Barbara Leuchs, and Jacek Hajda
- Abstract
Virus shedding in feces
- Published
- 2023
29. Personnes en formation et facturation via l039AOS
- Author
-
Thomas Gchter, Gregori Werder, Ueli Kieser, Gabriela Lang, and Iris Herzog-Zwitter
- Subjects
Microbiology (medical) ,Immunology ,Immunology and Allergy - Published
- 2023
30. Personen in Weiterbildung und die Verrechnung ber die OKP
- Author
-
Thomas Gchter, Gregori Werder, Ueli Kieser, Gabriela Lang, and Iris Herzog-Zwitter
- Subjects
General Medicine - Published
- 2023
31. The Dawning of a New Enterprise: RNA Therapeutics for the Skin
- Author
-
Rachel Kieser, Shaheerah Khan, Nada Bejar, and Daniel Kiss
- Subjects
medicine_pharmacology_other - Abstract
Despite being under development for decades, RNA therapeutics have only recently emerged as viable platform technologies. The COVID-19 mRNA vaccines have demonstrated the promise and power of the platform technology. In response, novel RNA drugs are entering clinical trials at an accelerating rate. As the skin is the largest and most accessible organ, it has always been a preferred target for drug discovery. This holds true for RNA therapies as well, and multiple candidate RNA-based drugs are currently in development for an array of skin conditions. In this mini review, we catalog the RNA therapies currently in clinical trials for different dermatological diseases. We summarize the main types of RNA-related drugs and use examples of drugs currently in development to illustrate their key mechanism of action.
- Published
- 2023
32. Informed interpretation of metagenomic data by StrainPhlAn enables strain retention analyses of the upper airway microbiome
- Author
-
Nadja Mostacci, Tsering Monika Wüthrich, Léa Siegwald, Silas Kieser, Ruth Steinberg, Olga Sakwinska, Philipp Latzin, Insa Korten, and Markus Hilty
- Abstract
Background: Shotgun metagenomic sequencing has the potential to provide bacterial strain-level resolution which is of key importance to tackle a host of clinical questions. While bioinformatics tools that achieve strain-level resolution are available, thorough benchmarking is needed to validate their use for less investigated and low biomass microbiomes like those from the upper respiratory tract. Methods: We analyzed a previously published dataset of longitudinally collected nasopharyngeal samples from Bangladeshi infants (Microbiota & Health study) and a novel dataset of oropharyngeal samples from Swiss children with cystic fibrosis. Data from bacterial cultures were used for benchmarking the parameters of StrainPhlAn 3, a bioinformatic tool designed for strain-level resolution. In addition, StrainPhlAn 3 results were compared to metagenomic assemblies and whole-genome sequencing data of S. aureus strains. Finally, strain retention analyses were performed. Results: After optimizing the analytical parameters, we compared our results to culture gold standard methods and achieved sensitivity values of 87% (S. pneumoniae), 80% (M. catarrhalis), 75% (H. influenzae) and 57% (S. aureus) for 420 nasopharyngeal and 75% (H. influenzae) and 46% (S. aureus) for 260 oropharyngeal samples. Comparing the phylogenetic tree of the core genome of 50 S. aureus isolates with a corresponding marker gene tree generated by StrainPhlAn 3 revealed a striking similarity in tree topology for all but three samples indicating adequate strain resolution. Quantitative analyses of longitudinally collected samples revealed clear signatures of strain retention for the four analyzed species. Conclusions: Comparison of StrainPhlAn 3 results to data from bacterial cultures revealed that strain-level tracking of the respiratory microbiome is feasible despite high content of host DNA when parameters are carefully optimized to fit low biomass microbiomes. This allowed to perform strain retention analyses applied to relevant pathobionts which will help to better understand the longitudinal dynamics of the upper respiratory microbiome during health and disease.
- Published
- 2023
33. Delineating genotypes and phenotypes of individual cells from long-read single cell transcriptomes
- Author
-
Cheng-Kai Shiau, Lina Lu, Rachel Kieser, Kazutaka Fukumura, Timothy Pan, Hsiao-Yun Lin, Jie Yang, Eric L. Tong, GaHyun Lee, Yuanqing Yan, Jason T. Huse, and Ruli Gao
- Subjects
Article - Abstract
Single-cell nanopore sequencing of full-length mRNAs (scNanoRNAseq) is transforming singlecell multi-omics studies. However, challenges include computational complexity and dependence on short-read curation. To address this, we developed a comprehensive toolkit, scNanoGPS to calculate same-cell genotypes-phenotypes without short-read guidance. We applied scNanoGPS onto 23,587 long-read transcriptomes from 4 tumors and 2 cell lines. Standalone, scNanoGPS accurately deconvoluted error-prone long-reads into single-cells and single-molecules. Further, scNanoGPS simultaneously accessed both phenotypes (expressions/isoforms) and genotypes (mutations) of individual cells. Our analyses revealed that tumor and stroma/immune cells often expressed significantly distinct combinations of isoforms (DCIs). In a kidney tumor, we identified 924 genes with DCIs involved in cell-type-specific functions such asPDE10Ain tumor cells andCCL3in lymphocytes. Moreover, transcriptome-wide mutation analyses identified many cell-type-specific mutations includingVEGFAmutations in tumor cells andHLA-Amutations in immune cells, highlighting critical roles of different populations in tumors. Together, scNanoGPS facilitates applications of single-cell long-read sequencing.
- Published
- 2023
34. Prediction for 2-Year Vision Outcomes Using Early Morphologic and Functional Responses in the Comparison of Age-related Macular Degeneration Treatments Trials
- Author
-
Katie Xue, Peiying Hua, Maureen G. Maguire, Ebenezer Daniel, Glenn J. Jaffe, Juan E. Grunwald, Gui-shuang Ying, David F. Williams, Sara Beardsley, Steven Bennett, Herbert Cantrill, Carmen Chan-Tram, Holly Cheshier, Kathyrn Damato, John Davies, Sundeep Dev, Julianne Enloe, Gennaro Follano, Peggy Gilbert, Jill Johnson, Tori Jones, Lisa Mayleben, Robert Mittra, Martha Moos, Ryan Neist, Neal Oestreich, Polly Quiram, Robert Ramsay, Edwin Ryan, Stephanie Schindeldecker, John Snater, Trenise Steele, Dwight Selders, Jessica Tonsfeldt, Shelly Valardi, Gary Edd Fish, Hank A. Aguado, Sally Arceneaux, Jean Arnwine, Kim Bell, Tina Bell, Bob Boleman, Patricia Bradley, David Callanan, Lori Coors, Jodi Creighton, Timothy Crew, Kimberly Cummings, Christopher Dock, Karen Duignan, Dwain Fuller, Keith Gray, Betsy Hendrix, Nicholas Hesse, Diana Jaramillo, Bradley Jost, Sandy Lash, Laura Lonsdale, Michael Mackens, Karin Mutz, Michael Potts, Brenda Sanchez, William Snyder, Wayne Solley, Carrie Tarter, Robert Wang, Patrick Williams, Stephen L. Perkins, Nicholas Anderson, Ann Arnold, Paul Blais, Joseph Googe, Tina T. Higdon, Cecile Hunt, Mary Johnson, James Miller, Misty Moore, Charity K. Morris, Christopher Morris, Sarah Oelrich, Kristina Oliver, Vicky Seitz, Jerry Whetstone, Bernard H. Doft, Jay Bedel, Robert Bergren, Ann Borthwick, Paul Conrad, Amanda Fec, Christina Fulwylie, Willia Ingram, Shawnique Latham, Gina Lester, Judy Liu, Louis Lobes, Nicole M. Lucko, Holly Mechling, Lori Merlotti, Keith McBroom, Karl Olsen, Danielle Puskas, Pamela Rath, Maria Schmucker, Lynn Schueckler, Christina Schultz, Heather Shultz, David Steinberg, Avni Vyas, Kim Whale, Kimberly Yeckel, David H. Orth, Linda S. Arredondo, Susan Brown, Barbara J. Ciscato, Joseph M. Civantos, Celeste Figliulo, Sohail Hasan, Belinda Kosinski, Dan Muir, Kiersten Nelson, Kirk Packo, John S. Pollack, Kourous Rezaei, Gina Shelton, Shannya Townsend-Patrick, Marian Walsh, H. Richard McDonald, Nina Ansari, Amanda Bye, Arthur D. Fu, Sean Grout, Chad Indermill, Robert N. Johnson, J. Michael Jumper, Silvia Linares, Brandon J. Lujan, Ames Munden, Meredith Persons, Rosa Rodriguez, Jennifer M. Rose, Brandi Teske, Yesmin Urias, Stephen Young, Richard F. Dreyer, Howard Daniel, Michele Connaughton, Irvin Handelman, Stephen Hobbs, Christine Hoerner, Dawn Hudson, Marcia Kopfer, Michael Lee, Craig Lemley, Joe Logan, Colin Ma, Christophe Mallet, Amanda Milliron, Mark Peters, Harry Wohlsein, Joel A. Pearlman, Margo Andrews, Melissa Bartlett, Nanette Carlson, Emily Cox, Robert Equi, Marta Gonzalez, Sophia Griffin, Fran Hogue, Lance Kennedy, Lana Kryuchkov, Carmen Lopez, Danny Lopez, Bertha Luevano, Erin McKenna, Arun Patel, Brian Reed, Nyla Secor, Iris R. Sison, Tony Tsai, Nina Varghis, Brooke Waller, Robert Wendel, Reina Yebra, Daniel B. Roth, Jane Deinzer, Howard Fine, Flory Green, Stuart Green, Bruce Keyser, Steven Leff, Amy Leviton, Amy Martir, Kristin Mosenthine, Starr Muscle, Linda Okoren, Sandy Parker, Jonathan Prenner, Nancy Price, Deana Rogers, Linda Rosas, Alex Schlosser, Loretta Studenko, Thea Tantum, Harold Wheatley, Michael T. Trese, Thomas Aaberg, Denis Bezaire, Craig Bridges, Doug Bryant, Antonio Capone, Michelle Coleman, Christina Consolo, Cindy Cook, Candice DuLong, Bruce Garretson, Tracy Grooten, Julie Hammersley, Tarek Hassan, Heather Jessick, Nanette Jones, Crystal Kinsman, Jennifer Krumlauf, Sandy Lewis, Heather Locke, Alan Margherio, Debra Markus, Tanya Marsh, Serena Neal, Amy Noffke, Kean Oh, Clarence Pence, Lisa Preston, Paul Raphaelian, Virginia R. Regan, Peter Roberts, Alan Ruby, Ramin Sarrafizadeh, Marissa Scherf, Sarita Scott, Scott Sneed, Lisa Staples, Brad Terry, Matthew T. Trese, Joan Videtich, George Williams, Mary Zajechowski, Daniel P. Joseph, Kevin Blinder, Lynda Boyd, Sarah Buckley, Meaghan Crow, Amanda Dinatale, Nicholas Engelbrecht, Bridget Forke, Dana Gabel, Gilbert Grand, Jennifer Grillion-Cerone, Nancy Holekamp, Charlotte Kelly, Ginny Nobel, Kelly Pepple, Matt Raeber, P. Kumar Rao, Tammy Ressel, Steven Schremp, Merrilee Sgorlon, Shantia Shears, Matthew Thomas, Cathy Timma, Annette Vaughn, Carolyn Walters, Rhonda Weeks, Jarrod Wehmeier, Tim Wright, Daniel M. Berinstein, Aida Ayyad, Mohammed K. Barazi, Erica Bickhart, Tracey Brady, Lisa Byank, Alysia Cronise, Vanessa Denny, Courtney Dunn, Michael Flory, Robert Frantz, Richard A. Garfinkel, William Gilbert, Michael M. Lai, Alexander Melamud, Janine Newgen, Shamekia Newton, Debbie Oliver, Michael Osman, Reginald Sanders, Manfred von Fricken, Pravin Dugel, Sandra Arenas, Gabe Balea, Dayna Bartoli, John Bucci, Jennifer A. Cornelius, Scheleen Dickens, Don Doherty, Heather Dunlap, David Goldenberg, Karim Jamal, Norma Jimenez, Nicole Kavanagh, Derek Kunimoto, John Martin, Jessica Miner, Sarah Mobley, Donald Park, Edward Quinlan, Jack Sipperley, Carol Slagle, Danielle Smith, Miguelina Yafchak, Rohana Yager, Christina J. Flaxel, Steven Bailey, Peter Francis, Chris Howell, Thomas Hwang, Shirley Ira, Michael Klein, Andreas Lauer, Teresa Liesegang, Ann Lundquist, Sarah Nolte, Susan K. Nolte, Scott Pickell, Susan Pope, Joseph Rossi, Mitchell Schain, Peter Steinkamp, Maureen D. Toomey, Debora Vahrenwald, Kelly West, Baker Hubbard, Stacey Andelman, Chris Bergstrom, Judy Brower, Blaine Cribbs, Linda Curtis, Jannah Dobbs, Lindreth DuBois, Jessica Gaultney, Deborah Gibbs, Debora Jordan, Donna Leef, Daniel F. Martin, Robert Myles, Timothy Olsen, Bryan Schwent, Sunil Srivastava, Rhonda Waldron, Andrew N. Antoszyk, Uma Balasubramaniam, Danielle Brooks, Justin Brown, David Browning, Loraine Clark, Sarah Ennis, Susannah Held, Jennifer V. Helms, Jenna Herby, Angie Karow, Pearl Leotaud, Caterina Massimino, Donna McClain, Michael McOwen, Jennifer Mindel, Candace Pereira, Rachel Pierce, Michele Powers, Angela Price, Jason Rohrer, Jason Sanders, Robert L. Avery, Kelly Avery, Jessica Basefsky, Liz Beckner, Alessandro Castellarin, Stephen Couvillion, Jack Giust, Matthew Giust, Maan Nasir, Dante Pieramici, Melvin Rabena, Sarah Risard, Robert See, Jerry Smith, Lisha Wan, Sophie J. Bakri, Nakhleh Abu-Yaghi, Andrew Barkmeier, Karin Berg, Jean Burrington, Albert Edwards, Shannon Goddard, Shannon Howard, Raymond Iezzi, Denise Lewison, Thomas Link, Colin A. McCannel, Joan Overend, John Pach, Margaret Ruszczyk, Ryan Shultz, Cindy Stephan, Diane Vogen, Reagan H. Bradford, Vanessa Bergman, Russ Burris, Amanda Butt, Beth Daniels, Connie Dwiggins, Stephen Fransen, Tiffany Guerrero, Darin Haivala, Amy Harris, Sonny Icks, Ronald Kingsley, Lena Redden, Rob Richmond, Brittany Ross, Kammerin White, Misty Youngberg, Trexler M. Topping, Steve Bennett, Sandy Chong, Mary Ciotti, Tina Cleary, Emily Corey, Dennis Donovan, Albert Frederick, Lesley Freese, Margaret Graham, Natalya Gud, Taneika Howard, Mike Jones, Michael Morley, Katie Moses, Jen Stone, Robin Ty, Torsten Wiegand, Lindsey Williams, Beth Winder, Carl C. Awh, Michelle Amonette, Everton Arrindell, Dena Beck, Brandon Busbee, Amy Dilback, Sara Downs, Allison Guidry, Gary Gutow, Jackey Hardin, Sarah Hines, Emily Hutchins, Kim LaCivita, Ashley Lester, Larry Malott, MaryAnn McCain, Jayme Miracle, Kenneth Moffat, Lacy Palazzotta, Kelly Robinson, Peter Sonkin, Alecia Travis, Roy Trent Wallace, Kelly J. Winters, Julia Wray, April E. Harris, Mari Bunnell, Katrina Crooks, Rebecca Fitzgerald, Cameron Javid, Corin Kew, Erica Kill, Patricia Kline, Janet Kreienkamp, Maricruz Martinez, Roy Ann Moore, Egbert Saavedra, LuAnne Taylor, Mark Walsh, Larry Wilson, Thomas A. Ciulla, Ellen Coyle, Tonya Harrington, Charlotte Harris, Cindi Hood, Ingrid Kerr, Raj Maturi, Dawn Moore, Stephanie Morrow, Jennifer Savage, Bethany Sink, Tom Steele, Neelam Thukral, Janet Wilburn, Joseph P. Walker, Jennifer Banks, Debbie Ciampaglia, Danielle Dyshanowitz, Jennifer Frederick, A. Tom Ghuman, Richard Grodin, Cheryl Kiesel, Eileen Knips, Jonathan McCue, Maria Ortiz, Crystal Peters, Paul Raskauskas, Etienne Schoeman, Ashish Sharma, Glenn Wing, Rebecca Youngblood, Suresh R. Chandra, Michael Altaweel, Barbara Blodi, Kathryn Burke, Kristine A. Dietzman, Justin Gottlieb, Gene Knutson, Denise Krolnik, T. Michael Nork, Shelly Olson, John Peterson, Sandra Reed, Barbara Soderling, Guy Somers, Thomas Stevens, Angela Wealti, Srilaxmi Bearelly, Brenda Branchaud, Joyce W. Bryant, Sara Crowell, Sharon Fekrat, Merritt Gammage, Cheala Harrison, Sarah Jones, Noreen McClain, Brooks McCuen, Prithvi Mruthyunjaya, Jeanne Queen, Neeru Sarin, Cindy Skalak, Marriner Skelly, Ivan Suner, Ronnie Tomany, Lauren Welch, Susanna S. Park, Allison Cassidy, Karishma Chandra, Idalew Good, Katrina Imson, null Sashi, null Kaur, Helen Metzler, Lawrence Morse, Ellen Redenbo, Marisa Salvador, David Telander, Mark Thomas, Cindy Wallace, Charles C. Barr, Amanda Battcher, Michelle Bottorff, Mary Chasteen, Kelly Clark, Diane Denning, Debra Schoen, Amy Schultz, Evie Tempel, Lisa Wheeler, Greg K. Whittington, Thomas W. Stone, Todd Blevins, Michelle Buck, Lynn Cruz, Wanda Heath, Diana Holcomb, Rick Isernhagen, Terri Kidd, John Kitchens, Cathy Sears, Ed Slade, Jeanne Van Arsdall, Brenda VanHoose, Jenny Wolfe, William Wood, John Zilis, Carol Crooks, Larry Disney, Mimi Liu, Stephen Petty, Sandra Sall, James C. Folk, Tracy Aly, Abby Brotherton, Douglas Critser, Connie J. Hinz, Stefani Karakas, Valerie Kirschner, Cheyanne Lester, Cindy Montague, Stephen Russell, Heather Stockman, Barbara Taylor, Randy Verdick, Jean Walshire, John T. Thompson, Barbara Connell, Maryanth Constantine, John L. Davis, null Gwen Holsapple, Lisa Hunter, C. Nicki Lenane, Robin Mitchell, Leslie Russel, Raymond Sjaarda, David M. Brown, Matthew Benz, Llewellyn Burns, JoLene G. Carranza, Richard Fish, Debra Goates, Shayla Hay, Theresa Jeffers, Eric Kegley, Dallas Kubecka, Stacy McGilvra, Beau Richter, Veronica Sneed, Cary Stoever, Isabell Tellez, Tien Wong, Ivana Kim, Christopher Andreoli, Leslie Barresi, Sarah Brett, Charlene Callahan, Karen Capaccioli, William Carli, Matthew Coppola, Nicholas Emmanuel, Claudia Evans, Anna Fagan, Marcia Grillo, John Head, Troy Kieser, Elaine Lee, Ursula Lord, Edward Miretsky, Kate Palitsch, Todd Petrin, Liz Reader, Svetlana Reznichenko, Mary Robertson, Justin Smith, Demetrios Vavvas, John Wells, Cassie Cahill, W. Lloyd Clark, Kayla Henry, David Johnson, Peggy Miller, LaDetrick Oliver, Robbin Spivey, Tiffany Swinford, Mallie Taylor, Michael Lambert, Kris Chase, Debbie Fredrickson, Joseph Khawly, Valerie Lazarte, Donald Lowd, Pam Miller, Arthur Willis, Philip J. Ferrone, Miguel Almonte, Rachel Arnott, Ingrid Aviles, Sheri Carbon, Michael Chitjian, Kristen DAmore, Christin Elliott, David Fastenberg, Barry Golub, Kenneth Graham, AnnMarie Lavorna, Laura Murphy, Amanda Palomo, Christina Puglisi, David Rhee, Juan Romero, Brett Rosenblatt, Glenda Salcedo, Marianne Schlameuss, Eric Shakin, Vasanti Sookhai, Richard Kaiser, Elizabeth Affel, Gary Brown, Christina Centinaro, Deborah Fine, Mitchell Fineman, Michele Formoso, Sunir Garg, Lisa Grande, Carolyn Herbert, Allen Ho, Jason Hsu, Maryann Jay, Lisa Lavetsky, Elaine Liebenbaum, Joseph Maguire, Julia Monsonego, Lucia O’Connor, Lisa Pierce, Carl Regillo, Maria Rosario, Marc Spirn, James Vander, Jennifer Walsh, Frederick H. Davidorf, Amanda Barnett, Susie Chang, John Christoforidis, Joy Elliott, Heather Justice, Alan Letson, Kathryne McKinney, Jeri Perry, Jill A. Salerno, Scott Savage, Stephen Shelley, Lawrence J. Singerman, Joseph Coney, John DuBois, Kimberly DuBois, Gregg Greanoff, Dianne Himmelman, Mary Ilc, Elizabeth McNamara, Michael Novak, Scott Pendergast, Susan Rath, Sheila Smith-Brewer, Vivian Tanner, Diane E. Weiss, Hernando Zegarra, Lawrence Halperin, Patricia Aramayo, Mandeep Dhalla, Brian Fernandez, Cindy Fernandez, Jaclyn Lopez, Monica Lopez, Jamie Mariano, Kellie Murphy, Clifford Sherley, Rita Veksler, Firas Rahhal, Razmig Babikian, David Boyer, Sepideh Hami, Jeff Kessinger, Janet Kurokouchi, Saba Mukarram, Sarah Pachman, Eric Protacio, Julio Sierra, Homayoun Tabandeh, Adam Zamboni, Michael Elman, Jennifer Belz, Tammy Butcher, Theresa Cain, Teresa Coffey, Dena Firestone, Nancy Gore, Pamela Singletary, Peter Sotirakos, JoAnn Starr, Travis A. Meredith, Cassandra J. Barnhart, Debra Cantrell, RonaLyn Esquejo-Leon, Odette Houghton, Harpreet Kaur, Fatoumatta NDure, Ronald Glatzer, Leonard Joffe, and Reid Schindler
- Subjects
Ophthalmology - Published
- 2023
35. The 45-year evolution of the Mathys RM monoblock cups: have the paradigm shifts been worthwhile?
- Author
-
Michael Foxall-Smith, Michael C Wyatt, Christopher Frampton, David Kieser, and Gary Hooper
- Subjects
Orthopedics and Sports Medicine ,Surgery - Abstract
Introduction: The Robert Mathys (RM) monoblock uncemented cup is a design less commonly used in primary total hip replacement. It’s purported advantages over modular cemented cups are: (1) its modulus of elasticity approximating bone, thus mimicking load transmission and the biomechanical behaviour of the cup to better match stresses on the acetabulum, leading to bone-preservation; and (2) as a 1-piece cup there is absence of a mobile interface between a liner and shell, preventing backside wear. Since its inception in 1983 there have been 3 major design changes: the RM Classic, the RM Pressfit, and the RM Vitamys with the most modern polyethylene (vitamin E). Methods: In a retrospective cohort study of the New Zealand Joint Registry, all designs of RM acetabular cup were reviewed. Data were included from1998 to 2018. All-cause revision rates, reasons for revision and the Oxford Hip Score (OHS) were assessed. Results: In total 13,272 acetabular cups were included. The all-cause revision rates did not differ between the designs. Revision rates for aseptic loosening in the RM Vitamys were lower, but the follow-up was shorter and more larger heads were used. There was no difference in the OHS. Conclusion: All implant designs were safe. The use of larger heads led to a decrease in revisions due to dislocation. It has to be waited out whether the RM Vitamys performs superior in the long-term due to the highly cross-linked polyethylene.
- Published
- 2022
36. Optimization of adaptive designs with respect to a performance score
- Author
-
Carolin Herrmann, Meinhard Kieser, Geraldine Rauch, and Maximilian Pilz
- Subjects
Statistics and Probability ,Research Design ,Sample Size ,General Medicine ,Statistics, Probability and Uncertainty - Abstract
Adaptive designs are an increasingly popular method for the adaptation of design aspects in clinical trials, such as the sample size. Scoring different adaptive designs helps to make an appropriate choice among the numerous existing adaptive design methods. Several scores have been proposed to evaluate adaptive designs. Moreover, it is possible to determine optimal two-stage adaptive designs with respect to a customized objective score by solving a constrained optimization problem. In this paper, we use the conditional performance score by Herrmann et al. (2020) as the optimization criterion to derive optimal adaptive two-stage designs. We investigate variations of the original performance score, for example, by assigning different weights to the score components and by incorporating prior assumptions on the effect size. We further investigate a setting where the optimization framework is extended by a global power constraint, and additional optimization of the critical value function next to the stage-two sample size is performed. Those evaluations with respect to the sample size curves and the resulting design's performance can contribute to facilitate the score's usage in practice.
- Published
- 2022
37. Dramatische Veränderungen der Altersstruktur bei Fachärzten im Bereich psychischer Gesundheit
- Author
-
Stefan Cohrs, Jens Rainer Pehlke, Wolfgang Jordan, Jens M. Langosch, Christian Kieser, and Thomas Pollmächer
- Subjects
Psychiatry and Mental health ,Neurology ,Neurology (clinical) ,General Medicine - Published
- 2022
38. Social Sin and the Sinless Savior: Delineating Supra‐Personal Sin in Continuity with Conciliar Christology
- Author
-
Daniel Lee Hill and Ty Kieser
- Subjects
Religious studies - Published
- 2022
39. The Holy Spirit and the Humanity of Christ in John Owen: A Re‐Examination
- Author
-
Ty Kieser
- Subjects
Religious studies - Published
- 2022
40. A preliminary study of rapid measurements of aqueous 210Po by accelerator mass spectrometry
- Author
-
Zilin Zhou, Xiaolei Zhao, William E. Kieser, and R. Jack Cornett
- Subjects
Spectroscopy ,Analytical Chemistry - Abstract
This study covers the preliminary assessment of a novel accelerator mass spectrometry technique for rapid quantitation of polonium-210 in water samples.
- Published
- 2022
41. Ballistic trauma caused by military rifles: experimental study based on synthetic skull proxies
- Author
-
Seth C. Taylor, Benjamin Ondruschka, David C. Kieser, Niels Hammer, Matthew Lee, Gary J. Hooper, and Elena Kranioti
- Subjects
Firearms ,Military Personnel ,Forensic Ballistics ,Skull ,Humans ,Pilot Projects ,Wounds, Gunshot ,General Medicine ,Models, Biological ,Pathology and Forensic Medicine - Abstract
Rifles are often involved in violent deaths such as homicide and suicide. Consequently, expert knowledge and experimental forensic investigations are important to clarify the nature of ballistic trauma when applied to the human head and neurocranium. This study investigated differences in entrance wound morphology with Synbone® spheres which are described as being comparable to human flat bones. A series of ballistic experiments were conducted using two different rifle calibers (5.56 × 45 mm and 7.62 × 39 mm Full Metal Jacket (FMJ)). Synbone® spheres were used for close-range 0.3 m simulated executions as well as at 25 m and 35 m to simulate urban and military engagements. Results were compared with previously published experimental studies using similar military ammunition. In our study, entry wound morphology closely resembles real forensic cases compared to exit wound and overall shape morphology independently of the distance and the caliber. Circumferential delamination was clearly visible with full metal jacket (FMJ) rounds, yielding similar damage pattern morphology to the human crania. This study documented the presence of hydraulic burst or shock in all ten rounds from all three distances. Krönlein shots were also observed in some cases. Synbone® spheres constitute an acceptable synthetic surrogate for ballistic experiments. The present study offers new initial data on the behavior of Synbone® proxies in ballistic testing of military ammunitions; FMJ gunshot injuries to the human head, for distances that have not previously been published, suggesting that efficient tests can take place under these conditions. Further research on experimental ballistics with a larger number of controlled factors and multiple repetitions is recommended to verify the results of this pilot study before applied in forensic simulations.
- Published
- 2022
42. Die italienische Reformbewegung
- Author
-
Luciana Degano Kieser
- Published
- 2022
43. 90° Spinning of Polyethylene Inserts in Mobile Bearing Unicompartmental Knee Arthroplasty
- Author
-
Connor Fitz-Gerald and David Kieser
- Subjects
musculoskeletal diseases ,Orthopedic surgery ,mobile bearing ,Medicine ,General Medicine ,unicompartmental knee arthroplasty ,RD701-811 - Abstract
Background The objective of this article is to describe for the first time a case of 90° spin out of a mobile bearing unicompartmental knee arthroplasty (UKA) polyethylene insert. In this report, we present a 57-year-old gentleman with a medial compartment UKA for osteoarthritis in 2017 who developed dislodgement and 90° rotation subsequent to traumatic injury when he was involved in a bus crash and impacted the anterolateral knee sustaining a valgus type injury 1 week postoperatively. Following the injury, he reported medial knee pain and a sensation of something moving within the joint. He was initially managed conservatively and progressed to full weight bearing; however, he experienced intermittent symptoms of catching and blocking of the joint, as well as medial knee swelling, that inhibited his ability to perform activities involving walking, kneeling, or pivoting. Imaging taken in 2018 show a 90° rotation of the polyethylene insert. These images showed the longitudinal metallic marker on the insert facing in an anteroposterior direction as opposed to the normal medial-lateral orientation. Failing conservative management, he presented to our clinic in 2019 and proceeded for revision of his UKA. Intraoperatively, his insert was reviewed and seen to easily spin on axis. The liner was therefore removed and upsized from a size 5 medium to a size 7 medium insert which provided excellent stability and stopped any further spinning. He has done tremendously well since the operation and reports full range of motion and no concerns. In patients with a history of pain, swelling, or locking following a UKA, it would be prudent to consider insert spinning, as well as the more common dislocation, through confirming the orientation of the metallic insert marker. Revision surgery to correct the spinning defect has proven effective with good resolution of symptoms and return to full range of motion.
- Published
- 2022
44. Missed Opportunities and Hope for Healing: Reflections of an Indigenous Catholic Priest–Interview with Fr. Daryold Winkler
- Author
-
Jane Barter, Doris Kieser, and Daryold Winkler
- Abstract
The context of my contribution to the roundtable discussion was intended to be from a personal perspective. I have Indigenous roots and am a second-generation survivor of the Indian Day School and Residential School system. For myself, the issue of reconciliation in the church is visceral because my mother and her siblings experienced the detrimental effects of these assimilation policies that we now know as cultural genocide. The effects of these policies continue to be felt in subsequent generations; they are intergenerational and they are traumatic.
- Published
- 2023
45. The Papal Apologies to Indigenous Peoples in Canada - Introduction
- Author
-
Doris Kieser
- Abstract
At the Canadian Theological Society conference in May 2022, a roundtable convened to discuss Pope Francis’ apology to Indigenous Peoples in Canada, offered in April 2022 in Rome. Each of the respondents, Archbishop Don Bolen (Regina, Saskatchewan), Dr. Christian Jamieson (Concordia University, Montreal, Quebec), Dr. Jeremy Bergen (Conrad Grebel University College, Waterloo, Ontario), and Rev. Daryold Winkler (Ottawa, Ontario), contributed insights and reflections from their own experiential and scholarly perspectives. Their contributions comprise the discussions that follow. Some of the respondents include reflections on the subsequent Papal visit to Canada in July 2022.
- Published
- 2023
46. Coping with Devils and Climate Change with the Help of Asceticism? Exploring the Role of Asceticism as Trigger of Collective Climate Action
- Author
-
Suleika Bort and Alfred Kieser
- Subjects
Philosophy ,General Environmental Science - Abstract
For much of European Christian history, asceticism has been associated with the capacity to transform individuals as well as societies. As an organised collaborative exercise in monasteries, asceticism enabled monks not only to live a life preparing for eternal life but also to generate ground-breaking technical and social innovations. Drawing on identity theories and recent developments in the social movement literature, we examine how asceticism has been the impetus for various individual and societal transformations and explore whether asceticism can still unfold such transformative power. In particular, we discuss whether and how ongoing movements for Voluntary Simplicity (VS) and further reflections on that, as found, for example, in the work of the sociologist Ulrich Beck, might assist humans in coping with climate change. Our article contributes to recent environmental ethics research by exploring the role of asceticism in potentially triggering collective climate action and its contribution to helping individuals to live meaningful lives in the face of climate change.
- Published
- 2023
47. Optimization of the two‐stage group sequential three‐arm gold‐standard design for non‐inferiority trials
- Author
-
Jan Meis, Maximilian Pilz, Carolin Herrmann, Björn Bokelmann, Geraldine Rauch, Meinhard Kieser, and Publica
- Subjects
Statistics and Probability ,non-inferiority ,Epidemiology ,gold-standard design ,hierarchical testing ,group sequential ,optimal design - Abstract
If design parameters are chosen appropriately, group sequential trial designs are known to be able to reduce the expected sample size under the alternative hypothesis compared to single-stage designs. The same holds true for the so-called 'gold-standard' design for non-inferiority trials, a design involving an experimental group, an active control group, and a placebo group. However, choosing design parameters that maximize the advantages of a two-stage approach for the three-arm gold-standard design for non-inferiority trials is not a straightforward task. In particular, optimal choices of futility boundaries for this design have not been thoroughly discussed in existing literature. We present a variation of the hierarchical testing procedure, which allows for the incorporation of binding futility boundaries at interim analyses. We show that this procedure maintains strong control of the family-wise type I error rate. Within this framework, we consider the futility and efficacy boundaries as well as the sample size allocation ratios as optimization parameters. This allows the investigation of the efficiency gain from including the option to stop for futility in addition to the ability to stop for efficacy. To analyze the extended designs, optimality criteria that include the design's performance under the alternative as well as the null hypothesis are introduced. On top of this, we discuss methods to limit the allocation of placebo patients in the trial while maintaining relatively good operating characteristics. The results of our numerical optimization procedure are discussed and a comparison of different approaches to designing a three-arm gold-standard non-inferiority trial is provided.
- Published
- 2023
48. An unbiased, stochastic echo-counting model
- Author
-
Kieser, R. and Ehrenberg, J. E.
- Subjects
Fisheries and aquaculture ,Technologies and data - Abstract
Traditional echo counting is an apparently simple fisheries acoustic tool that can provide quantitative estimates of fish density and abundance. The method has been widely used as it requires a minimum of equipment and the data analysis is deceptively simple. Several echo-counting methods have been described in the literature. These generally assume that the fish are all of the same acoustic size. This unrealistic assumption has led us to develop a new. stochastic echo-counting model that accounts for the wide distribution in acoustic fish sizes that is typical even for a group of fish of the same size. The new parametric model uses the Rayleigh or Rice probability density function to describe the wide distribution in acoustic fish size. Our major conclusions are that the traditional model may lead to a biased fish-density estimate and that better estimates of the mean acoustic fish size and other model parameters are very important.
- Published
- 2023
- Full Text
- View/download PDF
49. Adherence to the Obeid coronal malalignment classification and a residual malalignment below 20 mm can improve surgical outcomes in adult spine deformity surgery
- Author
-
Baroncini, Alice, Frechon, Paul, Bourghli, Anouar, Smith, Justin S., Larrieu, Daniel, Pellisé, Ferran, Pizones, Javier, Kleinstueck, Frank, Alanay, Ahmet, Kieser, David, Cawley, Derek T., Boissiere, Louis, Obeid, Ibrahim, and European Spine Study Group (ESSG)
- Abstract
European spine journal (2023). doi:10.1007/s00586-023-07831-0, Published by Springer, Berlin ; Heidelberg
- Published
- 2023
- Full Text
- View/download PDF
50. Certification of Uranium Isotope Amount Ratios in a Suite of Uranium Ore Concentrate Certified Reference Materials
- Author
-
Celia Venchiarutti, Lu Yang, Zoltán Mester, Mostafa Fayek, Xiaolei Zhao, Ying Gao, Zsolt Varga, Juan He, Eduardo A. Gautier, Yoshiki Kimura, Juris Meija, J. D. Inglis, Csaba Tobi, Klaus Mayer, Victoria Genetti, Maria Wallenius, Ryan Sharpe, Kyle M. Samperton, Yetunde Aregbe, Joanna S. Denton, Ali El-Jaby, Andreea Elena Serban, Jung Youn Choi, Viorel Fugaru, B.B.A. Francisco, William E. Kieser, Stephan Richter, Rachel E. Lindvall, Marian Virgolici, Kenny Nadeau, José Luis Ramella, Ruoxi Zhang, Hana Seo, A.A. Reinhard, and Paola Alejandra Babay
- Subjects
Waste management ,Isotopes of uranium ,Mc icp ms ,Suite ,010401 analytical chemistry ,Geology ,Certification ,010403 inorganic & nuclear chemistry ,certified reference materials ,01 natural sciences ,0104 chemical sciences ,Uranium ore ,Certified reference materials ,Geochemistry and Petrology ,uranium ore concentrate ,Environmental science ,MC-ICP-MS ,TIMS ,U isotope ratio - Abstract
In this study, data from thirteen laboratories from around the world are presented for a successful certification of uranium isotope ratios in uranium ore concentrate (UOC) certified reference materials from the National Research Council Canada. Different mass spectrometric measurement principles (including SF-ICP-MS, quadruple ICP-MS, TIMS, MC-ICP-MS, SIMS and AMS) and measurement procedures were employed. In general, data from all sources exhibit good consistency with TIMS and MC-ICP-MS showing superior performance. The three candidate UOC CRMs (UCLO-1, UCHI-1 and UPER-1) have natural uranium isotope ratios with certified values of 0.5304(7) × 10⁻⁴, 0.5475(2) × 10⁻⁴ and 0.5361(4) × 10⁻⁴ for n(²³⁴U)/n(²³⁸U) and 0.007 2563(13), 0.007 2563(10) and 0.007 2542(11) for n(²³⁵U)/n(²³⁸U), respectively, with expanded uncertainty (k = 2) applicable to the last digit of the value given in the parentheses. Information values for n(²³⁶U)/n(²³⁸U) in these three CRMs, measured by AMS, are also provided: 10 × 10⁻¹², 200 × 10⁻¹² and 22 × 10⁻¹². The uncertainties of the proposed certified values of uranium isotope ratios in UOC CRMs are superior to available reference materials, and the values of n(²³⁴U)/n(²³⁸U) and n(²³⁶U)/n(²³⁸U) show significant variation among the three CRMs.
- Published
- 2021
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.